Nadège Presneau

9.2k total citations · 1 hit paper
33 papers, 2.7k citations indexed

About

Nadège Presneau is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Nadège Presneau has authored 33 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Rheumatology. Recurrent topics in Nadège Presneau's work include Sarcoma Diagnosis and Treatment (12 papers), Bone Tumor Diagnosis and Treatments (10 papers) and Cancer-related molecular mechanisms research (6 papers). Nadège Presneau is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), Bone Tumor Diagnosis and Treatments (10 papers) and Cancer-related molecular mechanisms research (6 papers). Nadège Presneau collaborates with scholars based in United Kingdom, Canada and France. Nadège Presneau's co-authors include Adrienne M. Flanagan, Roberto Tirabosco, Dina Halai, Fitim Berisha, Maria Fernanda Amary, Stephen Henderson, Malihe Eskandarpour, Chris Boshoff, P. Andrew Futreal and Stephen Damato and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Oncogene.

In The Last Decade

Nadège Presneau

33 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

2011 716 citations Maria Fernanda Amary, Francesca Maggiani et al. The Journal of Pathology profile →

Peers

Countries citing papers authored by Nadège Presneau

Since Specialization

Citations

This map shows the geographic impact of Nadège Presneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadège Presneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadège Presneau more than expected).

Fields of papers citing papers by Nadège Presneau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadège Presneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadège Presneau. The network helps show where Nadège Presneau may publish in the future.

Co-authorship network of co-authors of Nadège Presneau

This figure shows the co-authorship network connecting the top 25 collaborators of Nadège Presneau. A scholar is included among the top collaborators of Nadège Presneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadège Presneau. Nadège Presneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Renal tumouroids: challenges of manufacturing 3D cultures from patient derived primary cells 2022 ·Journal of Cell Communication and Signaling ·Agata Nyga, Katerina Stamati, (unknown), (unknown), Andrew Feber, Joana B. Neves, Rifat Hamoudi, Nadège Presneau, Soha El Sheikh, Maxine Tran, Mark Emberton, Marilena Loizidou, Umber Cheema	8
2	Post-translational regulation contributes to the loss of LKB1 expression through SIRT1 deacetylase in osteosarcomas 2017 ·British Journal of Cancer ·Nadège Presneau, (unknown), Hongtao Ye, Roberto Tirabosco, Adrienne M. Flanagan, Malihe Eskandarpour	15
3	Next-generation sequencing is highly sensitive for the detection of beta-catenin mutations in desmoid-type fibromatoses 2015 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Sarah J. Aitken, Nadège Presneau, Sangeetha Kalimuthu, Palma Dileo, Fitim Berisha, Roberto Tirabosco, Maria Fernanda Amary, Adrienne M. Flanagan	33
4	Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics 2014 ·Genome Medicine ·Paul Guilhamon, Lee M Butcher, Nadège Presneau, Gareth A. Wilson, Andrew Feber, Dirk S. Paul, Moritz Schütte, Johannes Haybaeck, Ulrich Keilholz, (unknown), Mark T. Ross, Adrienne M. Flanagan, Stephan Beck	19
5	An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma 2012 ·The Journal of Pathology ·Andrew C. Nelson, Nischalan Pillay, Stephen Henderson, Nadège Presneau, Roberto Tirabosco, Dina Halai, Fitim Berisha, Paul Flicek, Derek L. Stemple, Claudio D. Stern, Fiona C. Wardle, Adrienne M. Flanagan	70
6	A common single-nucleotide variant in T is strongly associated with chordoma 2012 ·Nature Genetics ·Nischalan Pillay, Vincent Plagnol, Patrick Tarpey, Samira Lobo, Nadège Presneau, Károly Szuhai, Dina Halai, Fitim Berisha, Stephen R. Cannon, Simon Mead, Dalia Kasperavičiūtė, Jutta Palmen, Philippa J. Talmud, Lars‐Gunnar Kindblom, Maria Fernanda Amary, Roberto Tirabosco, Adrienne M. Flanagan	92
7	IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours breakdown → 2011 ·The Journal of Pathology ·Maria Fernanda Amary, (unknown), Francesca Maggiani, Stephen Damato, Dina Halai, Fitim Berisha, Robin Pollock, Paul O’Donnell, Anita Grigoriadis, Tim C. Diss, Malihe Eskandarpour, Nadège Presneau, Pancras C.W. Hogendoorn, P. Andrew Futreal, Roberto Tirabosco, Adrienne M. Flanagan	716
8	Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2 2011 ·Nature Genetics ·Maria Fernanda Amary, Stephen Damato, Dina Halai, Malihe Eskandarpour, Fitim Berisha, Fiona Bonar, S. McCarthy, Valeria R. Fantin, Kimberly Straley, Samira Lobo, Will Aston, Claire L. Green, Rosemary E. Gale, Roberto Tirabosco, P. Andrew Futreal, Peter J. Campbell, Nadège Presneau, Adrienne M. Flanagan	276
9	The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target 2010 ·The Journal of Pathology ·Asem Shalaby, Nadège Presneau, Hongtao Ye, Dina Halai, Fitim Berisha, Bernadine Idowu, Andreas Leithner, Bernadette Liegl, (unknown), (unknown), Lars‐Gunnar Kindblom, Nicholas A. Athanasou, Maria Fernanda Amary, Pancras C.W. Hogendoorn, Roberto Tirabosco, Adrienne M. Flanagan	86
10	Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas 2009 ·Modern Pathology ·Asem Shalaby, Nadège Presneau, Bernadine Idowu, Lisa Thompson, (unknown), Roberto Tirabosco, Timothy C. Diss, Adrienne M. Flanagan	32
11	GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma 2009 ·Modern Pathology ·David Delaney, Tim C. Diss, Nadège Presneau, Sandra Hing, Fitim Berisha, Bernadine Idowu, Paul O’Donnell, John Skinner, Roberto Tirabosco, Adrienne M. Flanagan	72
12	Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway 2009 ·British Journal of Cancer ·Nadège Presneau, Asem Shalaby, Bernadine Idowu, Panagiotis D. Gikas, S. R. Cannon, Ivan Gout, TC Diss, Roberto Tirabosco, Adrienne M. Flanagan	94
13	Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas 2006 ·The Journal of Pathology ·Sonja Vujović, Stephen Henderson, Nadège Presneau, Edward Odell, (unknown), Roberto Tirabosco, Chris Boshoff, Adrienne M. Flanagan	395
14	Identification of novel variant, 1484delG in the 3'UTR of H3F3B, a member of the histone 3B replacement family, in ovarian tumors 2005 ·International Journal of Oncology ·Nadège Presneau, Zhen Shen, Diane Provencher, Anne‐Marie Mes‐Masson, Patricia N. Tonin	3
15	A molecular map of mesenchymal tumors 2005 ·Genome biology ·Stephen Henderson, David B. Guiliano, Nadège Presneau, (unknown), (unknown), Sonja Vujović, John Anderson, Neil J. Sebire, Jeremy Whelan, Nick Athanasou, Adrienne M. Flanagan, Chris Boshoff	111
16	The Quest for a Tumor Suppressor Gene Phenotype 2003 ·Current Molecular Medicine ·Nadège Presneau, (unknown), Patricia N. Tonin	18
17	Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines 2003 ·Oncogene ·Nadège Presneau, Anne‐Marie Mes‐Masson, Bing Ge, Diane Provencher, Thomas J. Hudson, Patricia N. Tonin	27
18	Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer 2002 ·Molecular Carcinogenesis ·(unknown), Nadège Presneau, Diane Provencher, Anne‐Marie Mes‐Masson, Patricia N. Tonin	22
19	Systematic sequencing of the BRCA-1 coding region for germ-line mutation detection in 70 French high-risk families. 1999 ·International Journal of Oncology ·(unknown), Nadège Presneau, (unknown), Fabrice Kwiatkowski, Alain Lortholary, Agnès Hardouin, Yves‐Jean Bignon	4
20	New mechanism of BRCA-1 mutation by deletion/insertion at the same nucleotide position in three unrelated French breast/ovarian cancer families 1998 ·Human Genetics ·Nadège Presneau, (unknown), (unknown), Alain Lortholary, Agnès Hardouin, Dominique Bernard-Gallon, Y. J. Bignon	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact